Implantable
medical device eluting
drug locally and in prolonged period is provided, including several types of such a device, the treatment
modes of implementation and methods of implantation. The device comprising of polymeric substrate, such as a matrix for example, that is used as the device body, and drugs, and in some cases additional scaffolding materials, such as metals or additional polymers, and materials to enhance
visibility and imaging. The selection of
drug is based on the advantageous of releasing
drug locally and in prolonged period, where drug is released directly to the
extracellular matrix (ECM) of the diseased area such as tumor,
inflammation, degeneration or for symptomatic objectives, or to injured
smooth muscle cells, or for prevention. One kind of drug is the
gene silencing drugs based on
RNA interference (RNAi), including but not limited to si
RNA, sh
RNA, or
antisense RNA /
DNA,
ribozyme and
nucleoside analogs. The
modes of implantation in some embodiments are existing implantation procedures that are developed and used today for other treatments, including
brachytherapy and
needle biopsy. In such cases the dimensions of the new
implant described in this invention are similar to the original
implant. Typically a few devices are implanted during the same
treatment procedure.